Retatrutide showing promise in obesity and type 2 diabetes
Volume: 2.5 mg / 5 mg/mL = 0.50 mL
Tang H, Lu Y, Donahoo WT, Shao H, Shi L, Fonseca VA, et al
Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year
Self-administration means fewer weight management center visits Benefit Body Mounjaro comes in an easy-to-use pen formulation
Until these results are available and regulatory review is complete, the evidence base, whilst promising, should be interpreted with appropriate caution